The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: Proposals for tumourimmunotherapy and vaccine

Medical Hypotheses

Volumn 50, Issue 5, 1998, Pages 409-413

  Manzo, G ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; TUMOR VACCINE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL;

EID: 0031746169     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90213-4     Document Type: Article

References (20)

1. Manzo G. Phylogenesis, ontogenesis, oncogenesis. Med Hypotheses 1989; 30: 245-257.
2. Oppenheimer S B. Elementi di Embriologia. Bologna: Zanichelli, 1990: 142.
3. Welch W J. Come le cellule reagiscono allo stress. Le Scienze (Italian edition of Scientific American) 1993; 229: 50-57.
4. Balinsky B I. Introduzione alla Embriologia. Bologna: Zanichelli, 1970: 237.
5. Manzo G. Immunological correlations between ontogenesis and oncogenesis: theoretical implications and suggestions for tumor immunotherapy. Med Hypotheses 1992; 37: 166-170.
6. Manzo G. Cancer: a biological problem without any natural immunological solution? A unified theory with implications for grafts, pregnancy and tumor immunoprophylaxis. Med Hypotheses 1995; 45: 317-324.
7. Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldmann M. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res 1991; 51: 6372-6380.
8. Parmiani G, Anichini A, Fossati G. Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J Natl Cancer Inst 1990; 82: 361-370.
9. Herberman R B, Ortaldo J R. Natural killer cells: their role in defenses against disease. Science 1981; 214: 24-30.
10. Mayer M M. Il sistema complemento. In: La Nuova Immunologia. Milano: Le Scienze Spa Editore, 1992: 172-182.
11. Lebow L T, Bonavida B. Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets. Proc Natl Acad Sci USA 1990; 87: 6063-6067.
12. Grossi C E, Zarcone D, Nocera A. Morfologia e fenotipo dei linfociti umani. In: La Nuova Immunologia. Milano: Le Scienze Spa Editore, 1992: 89-98.
13. Schantz S P, Ordonez N. Natural killer cell activity predicts metastases from poorly-differentiated head and neck cancer. Proc Am Assoc Cancer Res 1988; 29: 374.
14. Gorelik E, Wiltrout R H, Okumura K, Halru S, Herberman R B. Role of NK cells in the control of metastatic spread of tumor cells in mice. Int J Cancer 1982; 30: 107-112.
15. Schantz S P, Goepfert H G. Multimodality therapy and distant metastases: the impact of natural killer cell activity. Arch Otolaryngol Head Neck Surg 1987; 113: 1207.
16. Sjogren H O, Hellstrom I, Bansal S C et al. Suggestive evidence that the 'blocking antibodies' of tumor-bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci USA 1971; 145: 1372.
17. MacKay W D. The incidence of allergic disorders and cancer. Br J Cancer 1966; 20: 434.
18. Meers P D. Allergy and cancer. Lancet 1973; i: 884.
19. Dionigi R, Zonta A. Immunobiologia delle Neoplasie. Padova: Piccin Editore, 1978: 168, 171.
20. Larsson A, Perlmann P. Study of Fab and F(ab)2 from rabbit IgG for capacity to induce lymphocyte-mediated target cell destruction in vitro. Int Arch Allergy Appl Immunol 1972; 43: 80.